Kenny Walter

New research shows no significant difference in the proportion of patients with gastrointestinal bleeding following anticoagulant or antiplatelet monotherapy.

Physically active geriatric adults are generally healthier physically and mentally than inactive older adults.

Coronary microvascular dysfunction is independently related to abnormal cardiac mechanics, according to a new study.

In a new study, investigators show how general anesthesia significantly increases the odds of postpartum depression and suicidal ideation following a cesarean delivery.

A 28-day patient log of gastrointestinal symptoms, stool consistency, psychological distress, and extraintestinal pain ratings informs investigators on the significance of markers.

Investigators find that male children have higher odds of taking ADHD medication than female children.

Investigators link waist circumference with an increased risk of depression for patients with arterial stiffness.

Anita Clayton, MD, the David C. Wilson Professor and Chair of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia, reports on some of the exciting new treatments in the pipeline for depression.

Anita Clayton, the David C. Wilson Professor and Chair of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia, explains how doctors can talk to patients about some of the side effects from antipsychotic medications.

Mindfulness therapy, along with usual care for depression, results in a reduction in residual depressive symptoms.

Investigators will move forward with a phase 2 study testing AV-101 as a potential treatment for patients with Parkinson disease receiving levodopa-based therapy.

In a placebo-controlled study, CBD attenuated hippocampal-striatal functional connectivity and caused trend-level symptom reduction in psychosis patients.

Higher ACR levels following an acute kidney injury is linked to an increased risk of kidney disease progression.

In a clinical trial, roluperidone reduces the level of centrality associated with avolition for schizophrenia patients.

In an industry-wide survey, 72.2% of healthcare providers report satisfaction with their own success.

PDUFA target action date set for November 15, 2020 for the new combination olanzapine/samidorphan treatment.

Psilocybin, which is commonly found in psychedelic mushrooms, is linked with enduring antianxiety and antidepressant effects.

In a new study, investigators generate a global estimate for children with HCV infections in 249 countries and territories.

In a new study, investigators determine the death-censored risk of graft failure with structural kidney feature.

Patients with untreated obstructive sleep apnea have increased health care utilizations with increased costs across all points of service.

Quetiapine, an antipsychotic known to treat mood disorders, is linked to increasing the risk of traumatic brain injuries for patients suffering from Alzheimer disease.

The FDA’s safety summary claims the extended-release formulation does not exhibit much benefit after the first day of administration.

Hemodialysis deemed the best form of dialysis in a new study focusing on elderly patients with end-stage kidney disease.

Of the 176 adverse events found in a trial targeting ambroxol as a Parkinson disease drug, only 3 were deemed related to the treatment.

A new study finds women and patients with a recent history of hospitalization were more likely to be colonized with C. difficile.

In a nationwide cohort, clozapine shows the most mortality outcome benefit among schizophrenia antipsychotics.

The approval allows Lannett to move forward with a cocaine hydrochloride nasal solution, as an ester local anesthetic for nasal diagnostic procedures or surgeries.

Deceased donor kidneys could offer a solution to a major kidney shortage in the US.

In a new study, investigators link inflammatory bowel disease with a number of negative maternal and placental outcomes.

New data shows that SEP-363856 curtails most of the debilitating side effects linked to current schizophrenia drugs.